Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Prediction of the active compounds and mechanism of Biochanin A in the treatment of Legg-Calvé-Perthes disease based on network pharmacology and molecular docking

Fig. 6

Molecular docking. A The result of molecular docking. B The result of Western blot showed that biochanin A reduced the expression of TNF-α and increased the phosphorylation level of AKT1. Full-length blots are presented in Supplementary Figure 3. (n = 3) C, D Statistical analysis of the phosphorylation level of AKT1 (C) and the expression level of TNF-α (D). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us